Fortress Biotech, Inc.'s Net Worth
$44.9 Million
Who is Fortress Biotech, Inc.?
Fortress Biotech, Inc. has an estimated net worth of $44.9 Million. This is based on reported shares across multiple companies, which include Checkpoint Therapeutics, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., NATIONAL HOLDINGS CORP, CB Pharma Acquisition Corp., and Journey Medical Corp.
SEC CIK
Fortress Biotech, Inc.'s CIK is 0001429260
Past Insider Trading and Trends
2023 was Fortress Biotech, Inc.'s most active year for acquiring shares with 10 total transactions. Fortress Biotech, Inc.'s most active month to acquire stocks was the month of December. 2022 was Fortress Biotech, Inc.'s most active year for disposing of shares, totalling 3 transactions. Fortress Biotech, Inc.'s most active month to dispose stocks was the month of April. 2023 saw Fortress Biotech, Inc. paying a total of $301,255.20 for 4,276,720 shares, this is the most they've acquired in one year. In 2022 Fortress Biotech, Inc. cashed out on 150,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Checkpoint Therapeutics, Inc. (CKPT) Snapshot price: $2.14
InvestorFortress Biotech, Inc. owns 2,702,705 units of Common Stock, $0.0001 par value which is worth $5,783,788.70 and 2,096,278 units of COMMON STOCK, PAR VALUE $0.0001 which is worth $4,486,034.92. In the year 2023 Fortress Biotech, Inc. acquired a total of 1,683,171 shares in Checkpoint Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +10.19% | 193.91K |
—
|
—
| 2.1M |
Mar 20
| |||
Form 4
| +9.07% | 158.13K |
—
|
—
| 1.9M |
Dec 29
| |||
Form 4
| +4.86% | 80.91K |
—
|
—
| 1.74M |
Sep 25
| |||
Form 4
| +5.15% | 81.41K |
—
|
—
| 1.66M |
Jun 30
| |||
Form 4
| +5.20% | 78.21K |
—
|
—
| 1.58M |
Mar 31 - Apr 4
| |||
Form 4
| +32.51% | 368.91K |
—
|
—
| 1.5M |
Jan 5
| |||
Form 4
| +36.43% | 721.7K |
—
|
—
| 2.7M |
Mar 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $2.84
InvestorFortress Biotech, Inc. owns 3,547,393 units of COMMON STOCK, PAR VALUE $0.0001 which is worth $10,074,596.12 and 1,032,390 units of Common Stock which is worth $2,931,987.60. In the year 2023 Fortress Biotech, Inc. acquired a total of 3,308,057 shares in AVENUE THERAPEUTICS, INC. at a cost of $301,255.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.19% | 413.51K |
—
|
—
| 3.55M |
Apr 16
| |||
Form 4
| +203.56% | 2.1M |
—
|
—
| 3.13M |
Jan 2
| |||
Form 4
| +68.15% | 418.41K |
$0.72 | $301,255.20 | 1.03M |
Sep 8
| |||
Form 4
| +9.33% | 52.42K |
—
|
—
| 613.98K |
Mar 31
| |||
Form 4
| +134.63% | 322.23K |
—
|
—
| 561.56K |
Dec 31 - Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MUSTANG BIO, INC. (MBIO) Snapshot price: $0.2761
InvestorFortress Biotech, Inc. owns 10,132,653 units of Common Stock, $0.0001 par value which is worth $2,797,625.49 and 2,502,991 units of COMMON STOCK, PAR VALUE $0.0001 which is worth $691,075.82. From 2017 to 2024 Fortress Biotech, Inc. acquired a total of 4,933,944 shares in MUSTANG BIO, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.84% | 575.19K |
—
|
—
| 2.5M |
Jun 27
| |||
Form 4
| +27.78% | 419.09K |
—
|
—
| 1.93M |
Jan 2
| |||
Form 4
| +14.16% | 2.81M |
—
|
—
| 22.63M |
Jan 6
| |||
Form 4
| +12.59% | 1.13M |
—
|
—
| 10.13M |
Sep 30 - Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NATIONAL HOLDINGS CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CB Pharma Acquisition Corp. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -79.38% | -1.02M |
—
|
—
| 265K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| -7.22% | -100.00K |
—
|
—
| 1.28M |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||